Synthesis of 5-phenyl-5,6,7,8-tetrahydro-1,6-naphthyridines and 5-phenyl-6,7,8,9-tetrahydro-5H-pyrido[3,2-c]azepines as potential D1 receptor ligands

Journal of Heterocyclic Chemistry

Volumn 41, Issue 6, 2004, Pages 857-865

  Hussenether, Thomas ^a   Troschütz, Reinhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 5 PHENYL 1,5,6,7,8,9 HEXAHYDRO 2H PYRIDO[3,2 C]AZEPIN 2 ONE; 3 AMINO 5 PHENYL 5,6,7,8 TETRAHYDRO 1,6 NAPHTHYRIDIN 2(1H) ONE; 5 PHENYL 1,5,6,7,8,9 HEXAHYDRO 2H PYRIDO[3,2 C]AZEPIN 2 ONE; 5 PHENYL 5,6,7,8 TETRAHYDRO 1,6 NAPHTHYRIDIN 2(1H) ONE; 5 PHENYL 5,6,7,8 TETRAHYDRO 1,6 NAPHTHYRIDINE; 5 PHENYL 6,7,8,9 TETRAHYDRO 5H PYRIDO[3,2 C]AZEPINE; 6 METHYL 5 PHENYL 5,6,7,8 TETRAHYDRO 1,6 NAPHTHYRIDINE; 6 METHYL 5 PHENYL 6,7,8,9 TETRAHYDRO 5H PYRIDO[3,2 C]AZEPINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHEMICAL REACTION; CYCLIZATION; DEHYDROGENATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; LIGAND BINDING;

EID: 12144261222     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570410602     Document Type: Article

References (29)

1. H. Blaschko, Brit. Med. Bull., 29, 105 (1973).
2. P. Seeman and H. H. M. Van Tol, Curr. Opin. Neurol. Neurosug., 6, 602 (1993).
3. A. K. Neve and R. L. Neve, in The Dopamine Receptors, K. A. Neve, R. L. Neve, eds., Humana Press, Totowa, New Jersey, 1997, pp 27-76.
4. M. Rowley, L. J. Bristow and P. H. Hutson, J. Med. Chem., 44, 477 (2001).
5. M. R. Weed, W. L. Woolverton and I. A. Paul, Eur. J. Pharmacol., 361, 129 (1998).
6. G. Thews, E. Mutschler and P. Vaupel, Anatomie, Physiologie, Pathophysiologie des Menschen, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1999, p 681.
7. J. L. Mc Nay, R. H. Mc Donald and L. I. Goldberg, Circulation Res., 16, 510 (1965).
8. C. I. Iorio, A. Barnett, F. H. Leitz, V. P. Houser and C. A. Korduba, J. Pharmacol. Exp. Ther., 226, 462 (1983).
9. F. Eiden, H. Lentzen, Pharmazie in unserer Zeit, 25, 28 (1996).
10. D. L. Minor, S. D. Wyrick, P. S. Charifson, V. J. Watts, D. E. Nichols, R. B. Mailman, J. Med. Chem., 37, 4317 (1994).
11. J. B. Post IV and W. H. Frishman, J. Clin. Pharmacol., 38, 2 (1998).
12. S. Ohta, A. Tsujimura and M. Okamoto, Chem. Pharm. Bull., 29, 2762 (1981).
13. B. Singh and D. Y. Lesher, J. Heterocyclic Chem., 27, 2085 (1990).
14. Y. Huang and R. W. Hartmann, Synth. Commun., 28, 1197 (1998).
15. K. Paulvannan and J. R. Stille, J. Org. Chem., 59, 1613 (1994).
16. I16] K. Paulvannan and T. Chen, J. Org. Chem., 65, 6160 (2000).
17. L. J. Beholz, P. Benovsky, D. L. Ward, N. S. Barta and J. R. Stille, J. Org. Chem., 62, 1033 (1997).
18. E. Coulon, M C. Caño de Andrade, V. Ratovelomanana-Vidal and J.-P. Genêt, Tetrahedron Lett., 39, 6467 (1998).
19. W. D. Jones, R. A. Schnettler and E. W. Huber, J. Heterocyclic Chem., 27, 511 (1990).
20. T. Shiori, K. Ninomiya and S. Yamada, J. Am. Chem. Soc., 67, 1017 (1945).
21. K. Ninomiya, T. Shiori, and S. Yamada, Tetrahedron, 20, 2151 (2151).
22. Organikum, Johann Ambrosius Barth Verlag, Heidelberg, Leipzig, 1996, pp 535-539.
23. A. Shiozawa, Y. Ichikawa, M. Ishihawa and H. Mirazaki, Ger. Offen. DE 3143016 A1 19820527 (1982); Chem. Abstr., 97, 144876 (1982).
24. H. T. Clarke, H. B.Gillespie and S. Z. Weisshaus, J. Am. Chem. Soc., 55, 4571 (1933).
25. P. S. Charifson, S. D. Wyrick, A. Hoffman and R. M. Simmons, J. Med. Chem., 31, 1941 (1988).
26. H. Hübner, C. Haubmann, W. Utz and P. Gmeiner, J. Med. Chem. 43, 756 (2000).
27. G. Hayes, T. J. Biden, L. A. Selbie and J. Shine, Mol. Endocrinol. 6, 920 (1992).
28. P. Sokoloff, M. Andrieux, R. Besançon, C. Pilon, M.-P. Martres, B. Giros and J.-C Schwartz, Eur. J. Pharmacol. 225, 331 (1992).
29. V. Asghari, S. Sanyal, S. Buchwaldt, A. Paterson, V. Jovanovic and H. H. M. Van Tol, J. Neurochem. 65, 1157 (1995).